Evidence map›Paper›PMID 40026684›Full record

ArticleStigma and health2025

Quitting smoking after a cancer diagnosis is associated with reductions in stigma and anxiety: A longitudinal mediation analysis.

Timothy J Williamson, Elyse R Park, Erica T Warner, Autumn W Rasmussen, Jamie S Ostroff

Abstract read
In one paragraph

Article in Stigma and health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Timothy J WilliamsonDepartment of Psychological Science, Loyola Marymount University, Los Angeles, CA, USA.ORCID 0000-0002-3678-0657
Elyse R ParkHealth Promotion and Resiliency Intervention Research Program, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0002-6319-264X
Erica T WarnerMongan Institute, Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0002-2671-0313
Autumn W RasmussenHealth Promotion and Resiliency Intervention Research Program, Massachusetts General Hospital, Boston, MA, USA.
Jamie S OstroffDepartment of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0003-2671-5680

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Integrating Tobacco Treatment into Cancer CareR01CA166147 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI PARK, ELYSE R. · 2012 to 2016
$3.6M
Examining Delivery of Integrated Tobacco Treatment in Cancer CareK24CA197382 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI PARK, ELYSE R. · 2015 to 2019
$841k
NIH Diversity Supplement (R00-CA-256351)R00CA256351 · NCI · LOYOLA MARYMOUNT UNIVERSITY · PI WILLIAMSON, TIMOTHY J · 2022 to 2024
$690k
Adapting and Testing a Novel Self-Compassion Intervention to Reduce Lung Cancer StigmaK99CA256351 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI WILLIAMSON, TIMOTHY J · 2021 to 2022
$249k
NCI NIH HHS K24 CA197382NCI NIH HHS K99 CA256351NCI NIH HHS L30 CA253424NCI NIH HHS P30 CA008748NCI NIH HHS R00 CA256351NCI NIH HHS R01 CA166147
6 · The paper itself

Abstract

Internalized cancer stigma is high among cancer patients who smoke, but it is unknown whether the experience of stigma changes after quitting smoking post-diagnosis. Using data from an RCT of tobacco treatment, we conducted a secondary data analysis and hypothesized that 1) cancer patients who quit smoking would report greater reductions in internalized cancer stigma, compared to patients who did not quit and that 2) greater reductions in stigma would significantly mediate the relationship between smoking abstinence and subsequent decreases in anxiety and depressive symptoms. Participants (n=303; 56.1% female) were adults recruited from two comprehensive cancer centers who had smoked in the past 30 days, spoke English or Spanish, and were being treated for a recent diagnosis of cancer. Participants completed questionnaires at baseline, 3-month follow-up, and 6-month follow-up, and biochemically verified smoking abstinence was determined by participants' salivary cotinine or carbon monoxide levels. Smoking abstinence at 3-month follow-up was significantly associated with reductions in cancer-related stigma from baseline to 3-month follow-up (b = -1.50,

Indexed as

anxietydepressive symptomslongitudinalsmoking cessationstigma

Identifiers

PMID40026684
PMCPMC11867195

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.